Official reports from the 2014 cooperative meeting of CMSC & ACTRIMS – 5/30/2014

A CMSC-administered database now in its developmental stages will provide clinicians, patients, researchers, and drug developers with real-world, longitudinal data to guide their decision-making, thus transforming all aspects of multiple sclerosis (MS) care, Kottil Rammohan, MD, said in the keynote lecture that opened Thursday’s session of the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX… Read More

Physicians and other health-care professionals need to move from “emotion-based medicine” to evidence-based medicine in assessing various complementary and alternative medicine (CAM) therapies for multiple sclerosis (MS) and in counseling patients regarding CAM… Read More

Healthcare providers and patients are experiencing the early stages of a technology revolution that will change all aspects of multiple sclerosis (MS) patient care and research, but – as with any revolution – there will be plenty of disruption, uncertainty, and false starts before the full benefits of technological advances are realized… Read More

Despite varied types of data suggesting that multiple sclerosis (MS) in African Americans is marked by differences in disease biology from MS in Caucasians, gaping holes in our understanding of those perceived differences persist and can be filled only by prospectively designed, multi-center trials, Omar Khan, MD, told a symposium audience yesterday at the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX… Read More

There’s a lot of work that needs to be done to come up with better outcome measures in progressive multiple sclerosis, Megan Hyland, MD, MS, told symposium attendees yesterday at the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX… Read More

Recent research lends support to the hypothesis that multiple sclerosis (MS) is marked by intraindividual pathological homogeneity and interindividual heterogeneity, Imke Metz, MD, told a symposium audience yesterday at the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX.

Dr. Metz, a neuropathologist at University Medical Center, Georg August University in Gottingen, Germany, noted that this hypothesis was advanced in a paper published in 2000 (Ann Neurol. 2000 Jun:47(6):707-17), in which Claudia F. Lucchinetti, MD, of the Mayo Clinic and other investigators assessed 51 biopsies and 32 autopsies that had been collected in three international center… Read More